|
Recent Developments |
|
27-SEP-13
Lifeline Drugs & Pharma said on Thursday its board of directors will meet on October 01, 2013 to consider splitting, sub-division of face value of equity shares.
26-SEP-13
Lifeline Drugs & Pharma said that its board of directors will meet on Oct. 01, 2013, to consider split/sub-division of face value of shares.
Future Plans
The company is expected to set up a greenfield project for manufacturing bulk drugs and intermediates and ... More.. |
| Business Profile |
Future Plans |
|
|
|
|
One To One
|
|
Recent news
|
|
|
| Brief Financials (in Rs. Mn.) | |
| Period ending (months) | 31-Dec-2015(9) | 31-Mar-2015 (12) | 31-Mar-2014 (12) | | Net sales | 63.70 | 427.02 | 400.78 | | Other Income | 9.42 | 16.48 | 7.68 | | Total Income | 73.12 | 443.50 | 408.46 | | Cost of goods sold | 67.05 | 434.37 | 398.69 | | OPBDIT | 6.07 | 9.13 | 9.77 | | PAT | 6.04 | 6.24 | 6.55 | | Gross Block | - | - | - | | Equity capital | 36.24 | 36.24 | 36.24 | | EPS (Rs.) | - | 0.17 | 0.18 | | DPS (Rs.) | - | - | - | | BV (Rs.) | - | - | - | | P/E range (x) | - | 941.18 - 1941.18 | 200.56 - 3246.39 | | Debt / Equity (x) | - | - | - | | Operating margin (% of OI) | 8.3 | 2.1 | 2.4 | | Net margin (% of OI) | 8.3 | 1.4 | 1.6 |
|
|
Detailed Financials
|
|
|
|
|
